About Craver
Craver is a company based in Seoul (South Korea) founded in 2014. It operates as a Direct-to-Consumer (D2C). Craver has raised $19.23 million across 5 funding rounds from investors including Korean Development Bank, POSCO and DSC Investment. Craver has completed 1 acquisition, including Picky. Craver offers products and services including SKIN1004, COMMONLABS, ZOMBIE BEAUTY, and IDENEL.
- Headquarter Seoul, South Korea
-
Sectors
HealthcareRetail
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Craver
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.23 M (USD)
in 5 rounds
-
Latest Funding Round
$15.17 M (USD), Series B
Dec 03, 2018
-
Investors
Korean Development Bank
& 9 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Craver
Craver offers a comprehensive portfolio of products and services, including SKIN1004, COMMONLABS, ZOMBIE BEAUTY, and IDENEL.
Skincare products are offered for various skin needs.
Skincare solutions are provided for diverse consumer needs.
Unique beauty products are developed for consumers.
Innovative beauty items are created for market trends.
Funding Insights of Craver
Craver has successfully raised a total of $19.23M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $15.17 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $15.2M
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Series B - Craver | Valuation | Angel Ventures , Kolmar Korea |
|
| Feb, 2016 | Amount | Series A - Craver | Valuation |
investors |
|
| Nov, 2015 | Amount | Seed - Craver | Valuation | Detong Capital |
|
Investors in Craver
Craver has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Korean Development Bank, POSCO and DSC Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Private equity & venture capital firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Craver
Craver has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Picky.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personalized skincare and beauty products are discovered through an app.
|
2020 |
Financial Statements - Craver
Craver Comparisons
Competitors of Craver
Frequently Asked Questions about Craver
Craver was founded in 2014.
Craver is headquartered in Seoul, South Korea.
Sohyeong Lee is the current CEO of Craver.
Craver is a funded company, having raised a total of $19.23M across 5 funding rounds to date.
Craver is involved in the development and nurturing of consumer goods brands, focusing on understanding and fulfilling diverse consumer desires. The company operates in the personal care sector, particularly in skincare and beauty, with brands like SKIN1004, COMMONLABS, ZOMBIE BEAUTY, and IDENEL. Solutions are crafted to meet market needs through innovative products and direct-to-consumer strategies.
Craver offers SKIN1004, COMMONLABS, ZOMBIE BEAUTY, and IDENEL.
Craver has made 1 acquisition, including Picky.
Craver has 10 investors. Key investors include Korean Development Bank, POSCO, DSC Investment, Kolmar Pharm, and KTB Network.